Hikma Pharmaceuticals PLC

HKMPF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$236$188$236$205
Short-Term Investments$0$25$24$24
Receivables$1,069$905$937$789
Inventory$1,082$986$936$891
Other Curr. Assets$170$159$152$191
Total Curr. Assets$2,557$2,263$2,285$2,100
Property Plant & Equip (Net)$1,373$1,326$1,137$1,141
Goodwill$393$382$383$388
Intangibles$824$774$711$712
Long-Term Investments$11$62$63$75
Tax Assets$294$293$0$226
Other NC Assets$102$33$268$38
Total NC Assets$2,997$2,870$2,562$2,580
Other Assets$0$0$0$0
Total Assets$5,554$5,133$4,847$4,680
Liabilities
Payables$611$358$541$309
Short-Term Debt$716$653$215$161
Tax Payable$86$78$0$74
Deferred Revenue$0$0$0$179
Other Curr. Liab.$643$889$708$616
Total Curr. Liab.$2,056$1,978$1,380$1,339
LT Debt$842$653$1,061$1,030
Deferred Rev, NC$25$30$0$0
Deferred Tax Liab, NC$17$18$26$25
Other NC Liab.$63$133$80$77
Total NC Liab.$947$834$1,167$1,132
Other Liabilities$0$0$0$0
Cap. Leases$54$57$53$66
Total Liabilities$3,003$2,812$2,547$2,471
Equity
Pref Stock$0$0$0$0
Common Stock$40$40$40$40
Retained Earnings$2,472$2,362$2,287$2,158
AOCI$0-$374-$323-$282
Other Equity$26$282$282$282
Total Equity$2,538$2,310$2,286$2,198
Supplemental Information
Minority Interest$13$11$14$11
Total Liab. & Tot. Equity$5,554$5,133$4,847$4,680
Net Debt$1,322$1,118$1,040$986